Skip to main content

After nearly $1 billion and 27 years, S.F. biotech now must wait another 90 days for 1st FDA decision

The company had expected an FDA decision by Sunday. Now the regular, wanting additional analyses of data from existing clinical trials, has moved the decision date to March 20.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.